Dentoxol Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Dentoxol General Information

Description

Developer of oral biomedicine designed for unmet oral health needs. The company's product portfolio covers a wide range of oral manifestations such as oral mucositis, aphthous stomatitis, and other oral injuries due to autoimmune diseases or mechanical damage, cold sores, and periodontitis, among others, enabling patients to control various oral pathologies by providing relief.

Contact Information

Formerly Known As
Ingalfarma
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Borgoño 71
  • Of. 1302
  • Providencia
  • Chile
+56 (2)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Borgoño 71
  • Of. 1302
  • Providencia
  • Chile
+56 (2)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dentoxol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 04-Jun-2026 Completed Out of Business
1. Later Stage VC Completed Generating Revenue
To view Dentoxol’s complete valuation and funding history, request access »

Dentoxol Patents

Dentoxol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023272404-A1 Oral pharmaceutical composition for preventing and/or treating diseases of the soft and hard tissues surrounding the tooth in the oral cavity Inactive 02-Jul-2021
ES-2885449-T3 Oral antiseptic composition for the treatment of oral mucositis Active 07-Feb-2013
EP-2957282-A1 Oral antiseptic composition for treating oral mucositis Active 07-Feb-2013
EP-2957282-A4 Oral antiseptic composition for treating oral mucositis Active 07-Feb-2013
EP-2957282-B1 Oral antiseptic composition for treating oral mucositis Active 07-Feb-2013 A61K31/045
To view Dentoxol’s complete patent history, request access »

Dentoxol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dentoxol Acquisitions (1)

Dentoxol’s most recent deal was a Merger/Acquisition with Level Bioscience. The deal was made on 01-Dec-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Level Bioscience 01-Dec-2017 Merger/Acquisition Drug Delivery
To view Dentoxol’s complete acquisitions history, request access »

Dentoxol FAQs

  • When was Dentoxol founded?

    Dentoxol was founded in 2006.

  • Where is Dentoxol headquartered?

    Dentoxol is headquartered in Providencia, Chile.

  • What is the size of Dentoxol?

    Dentoxol has 5 total employees.

  • What industry is Dentoxol in?

    Dentoxol’s primary industry is Pharmaceuticals.

  • Is Dentoxol a private or public company?

    Dentoxol is a Private company.

  • What is Dentoxol’s current revenue?

    The current revenue for Dentoxol is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process